Total Funding
22
37
Total FundingVenture - Series Unknown raised
Growth Score 22 in past quarter
-5 pts
Heat Score 37 in past quarter
-1 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
59806
AltheaDx offers molecular diagnostics and PCR-based services such as molecular biomarker discovery, assay development and assay validation.
Acquired by 
Castle Biosciences
- Magda Marquet: Co-FounderPast Role: Althea Technologies, Founder & co-Chairman
- Feng Cao: COO
About the Company
AltheaDx, Inc. provides molecular diagnostics and PCR-based services. It offers molecular biomarker discovery, assay development, assay validation, and prospective/retrospective clinical trial testing services. The company also provides gene expression and genotyping analysis for pre-clinical and clinical applications. In addition, it offers
discovery services, such as microarray analysis, real-time PCR, next-gen sequencing, quantitative PCR, mutation scanning, data analysis, race assay, and therapeutic siRNA; and diagnostic development services.
Women Founded


